Tag: generic drugs

Cost Savings from Generic Combinations: Comparing Individual Generics vs. Combination Drugs
By Celia Rawdon
Cost Savings from Generic Combinations: Comparing Individual Generics vs. Combination Drugs

Generic drugs can save you money-but not all generics are cheap. Some cost 15 times more than equally effective alternatives. Learn how combination drugs and smart substitutions can cut your prescription costs by up to 90%.

Future Approaches to Changing Perceptions of Generic Drugs
By Celia Rawdon
Future Approaches to Changing Perceptions of Generic Drugs

Generic drugs save billions but face stubborn perception gaps. Learn how new transparency tools, provider education, and biosimilars are changing how patients and providers view these proven, affordable medications.

Stability and Shelf Life: Understanding Generic Drug Degradation and Safety Risks
By Celia Rawdon
Stability and Shelf Life: Understanding Generic Drug Degradation and Safety Risks

Understanding how generic drugs maintain safety and potency over time through stability testing, storage conditions, and regulatory standards - and why expiration dates matter more than you think.

Community Health Presentations: Public Education Resources on Generic Drugs
By Celia Rawdon
Community Health Presentations: Public Education Resources on Generic Drugs

Learn how community health presentations are helping people understand that generic drugs are just as safe and effective as brand-name medicines-while saving billions in healthcare costs.

Pharmaceutical Prices across Different Countries: A Clear Comparison
By Celia Rawdon
Pharmaceutical Prices across Different Countries: A Clear Comparison

Pharmaceutical prices vary dramatically across countries due to policy differences. The U.S. has high list prices but low generic costs, while countries like Japan and France use negotiation and price caps to keep costs down. Medicare's new negotiation power is changing the landscape.

Pharmacy Margin Economics: How Generics Drive Profits in Today's Drug Market
By Celia Rawdon
Pharmacy Margin Economics: How Generics Drive Profits in Today's Drug Market

Generics make up 90% of prescriptions but only 25% of drug spending - yet they drive nearly all pharmacy profits. Here’s how the broken economics of PBMs, spreads, and clawbacks are reshaping who wins and who loses in the drug supply chain.

FDA Regulatory Authority: How the Agency Approves Generic Drugs
By Celia Rawdon
FDA Regulatory Authority: How the Agency Approves Generic Drugs

The FDA approves generic drugs through the ANDA process, ensuring they're as safe and effective as brand-name drugs without repeating costly clinical trials. Learn how bioequivalence, manufacturing standards, and regulatory timelines make generics affordable and reliable.